Pilib Ó. Broin

Pilib Ó. Broin

Auto-generated profile, based on publicly available information

Pilib Ó. Broin

Division of Computational Genetics, Department of Genetics, Albert Einstein College of Medicine, Bronx, New York, USA

Research Focus & Metrics

Academic Career Length

20Years (2007-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
16 November 2015 in Epigenetics & Chromatin
Verified
Journal Article
Open access
PDF file
JNJulie Nadel
Julie Nadel
RARodoniki Athanasiadou
Rodoniki Athanasiadou
CLChristophe Lemetre
Christophe Lemetre
NWN. Ari Wijetunga
N. Ari Wijetunga
PBPilib Ó Broin
Pilib Ó Broin
JGJohn M. Greally
John M. Greally
RNA:DNA hybrids represent a non-canonical nucleic acid structure that has been associated with a range of human diseases and potential transcriptional regulatory functions. Mapping of RNA:DNA hybrids in human cells reveals them to have a number of characteristics that give insights into their functions. We find RNA:DNA hybrids to occupy millions of base pairs in the human genome. A directional sequencing approach shows the RNA component of the RNA:DNA hybrid to be purine-rich, indicating a thermodynamic contribution to their in vivo stability. The RNA:DNA hybrids are enriched at loci with decreased DNA methylation and increased DNase hypersensitivity, and within larger domains with characteristics of heterochromatin formation, indicating potential transcriptional regulatory properties. Mass spectrometry studies of chromatin at RNA:DNA hybrids shows the presence of the ILF2 and ILF3 transcription factors, supporting a model of certain transcription factors binding preferentially to the RNA:DNA conformation. Overall, there is little to indicate a dependence for RNA:DNA hybrids forming co-transcriptionally, with results from the ribosomal DNA repeat unit instead supporting the intriguing model of RNA generating these structures in trans. The results of the study indicate heterogeneous functions of these genomic elements and new insights into their formation and stability in vivo.

15 December 2015 in Molecular Psychiatry
Verified
Journal Article
Open access
PDF file
TTT Takahashi
T Takahashi
SOS Okabe
S Okabe
PBP Ó Broin
P Ó Broin
ANA Nishi
A Nishi
KYK Ye
K Ye
NHNoboru Hiroi
Noboru Hiroi
A critical step toward understanding autism spectrum disorder (ASD) is to identify both genetic and environmental risk factors. A number of rare copy number variants (CNVs) have emerged as robust genetic risk factors for ASD, but not all CNV carriers exhibit ASD and the severity of ASD symptoms varies among CNV carriers. Although evidence exists that various environmental factors modulate symptomatic severity, the precise mechanisms by which these factors determine the ultimate severity of ASD are still poorly understood. Here, using a mouse heterozygous for Tbx1 (a gene encoded in 22q11.2 CNV), we demonstrate that a genetically triggered neonatal phenotype in vocalization generates a negative environmental loop in pup–mother social communication. Wild-type pups used individually diverse sequences of simple and complicated call types, but heterozygous pups used individually invariable call sequences with less complicated call types. When played back, representative wild-type call sequences elicited maternal approach, but heterozygous call sequences were ineffective. When the representative wild-type call sequences were randomized, they were ineffective in eliciting vigorous maternal approach behavior. These data demonstrate that an ASD risk gene alters the neonatal call sequence of its carriers and this pup phenotype in turn diminishes maternal care through atypical social communication. Thus, an ASD risk gene induces, through atypical neonatal call sequences, less than optimal maternal care as a negative neonatal environmental factor.

16 March 2017 in The Journals of Gerontology, Series A: Biological Sciences and Medical Sciences
Verified
Journal Article
Open access
PDF file
RPRena M Pollack
Rena M Pollack
NBNir Barzilai
Nir Barzilai
VAValentin Anghel
Valentin Anghel
AKAmeya Kulkarni
Ameya Kulkarni
AGAaron Golden
Aaron Golden
JCJill P Crandall
Jill P Crandall
Resveratrol, a plant-derived polyphenol, has been reported to improve glucose metabolism and vascular function and to extend life span in animal models, but studies in humans have been inconclusive. In a randomized, double-blind crossover study, we treated older glucose-intolerant adults (n = 30) with resveratrol (2−3 g/daily) or placebo, each for 6 weeks. A standard mixed-meal test was used to assess insulin sensitivity (Matsuda index) and secretion (C-peptide deconvolution) and vascular function by reactive hyperemia peripheral arterial tonometry. Skeletal muscle samples were obtained for gene expression using RNA-Seq analysis and to assess mitochondrial morphology. There were no changes in glucose tolerance, insulin sensitivity, weight, blood pressure, or lipid profile following resveratrol treatment. Fasting reactive hyperemia index improved with resveratrol (2.02 ± 0.2 vs 1.76 ± 0.02, p = .002). RNA-Seq analysis yielded 140 differentially expressed transcripts (corrected p-value ≤ .05), predominantly associated with mitochondrial genes and noncoding RNA. Ingenuity Pathway Analysis confirmed that mitochondrial dysfunction (p = 2.77 × 10−12) and oxidative phosphorylation (p = 1.41 × 10−11) were the most significantly perturbed pathways. Mitochondrial number, but not size, was increased. Resveratrol treatment of older adults with impaired glucose regulation may have beneficial effects on vascular function, but not glucose metabolism or insulin sensitivity. Changes in gene expression suggest effects similar to those observed with caloric restriction, which has been shown to increase life and health span in animal models, although its significance for humans is uncertain. Future human studies should address the appropriate dose range and low bioavailability of resveratrol.

1 January 2016 in Kidney International
Verified
Journal Article
Closed access
PDF file
AGAnjali Gupta
Anjali Gupta
PBPilib Ó. Broin
Pilib Ó. Broin
YBYi Bao
Yi Bao
JPJames Pullman
James Pullman
LKLayla Kamal
Layla Kamal
EAEnver Akalin
Enver Akalin

7 July 2009 in Proceedings of the National Academy of Sciences
Verified
Journal Article
Closed access
MKMarianne K.-H. Kim
Marianne K.-H. Kim
TMThomas J. McGarry
Thomas J. McGarry
PBPilib Ó Broin
Pilib Ó Broin
JFJared M. Flatow
Jared M. Flatow
AGAaron A.-J. Golden
Aaron A.-J. Golden
JLJonathan D. D Licht
Jonathan D. D Licht
WT1, a critical regulator of kidney development, is a tumor suppressor for nephroblastoma but in some contexts functions as an oncogene. A limited number of direct transcriptional targets of WT1 have been identified to explain its complex roles in tumorigenesis and organogenesis. In this study we performed genome-wide screening for direct WT1 targets, using a combination of ChIP–ChIP and expression arrays. Promoter regions bound by WT1 were highly G-rich and resembled the sites for a number of other widely expressed transcription factors such as SP1, MAZ, and ZNF219. Genes directly regulated by WT1 were implicated in MAPK signaling, axon guidance, and Wnt pathways. Among directly bound and regulated genes by WT1, nine were identified in the Wnt signaling pathway, suggesting that WT1 modulates a subset of Wnt components and responsive genes by direct binding. To prove the biological importance of the interplay between WT1 and Wnt signaling, we showed that WT1 blocked the ability of Wnt8 to induce a secondary body axis during Xenopus embryonic development. WT1 inhibited TCF-mediated transcription activated by Wnt ligand, wild type and mutant, stabilized β-catenin by preventing TCF4 loading onto a promoter. This was neither due to direct binding of WT1 to the TCF binding site nor to interaction between WT1 and TCF4, but by competition of WT1 and TCF4 for CBP. WT1 interference with Wnt signaling represents an important mode of its action relevant to the suppression of tumor growth and guidance of development.

1 February 2015 in International Journal of Radiation Oncology - Biology - Physics (IJROBP)
Verified
Journal Article
Closed access
PBPilib Ó Broin
Pilib Ó Broin
BVBhavapriya Vaitheesvaran
Bhavapriya Vaitheesvaran
SSSubhrajit Saha
Subhrajit Saha
KHKirsten Hartil
Kirsten Hartil
ECEmily I. Chen
Emily I. Chen
AGAaron Golden
Aaron Golden